Skip to main content
BMJ Neurology Open logoLink to BMJ Neurology Open
. 2025 Dec 23;7(2):e001325. doi: 10.1136/bmjno-2025-001325

Cerebellar ataxias and functional movement disorders: navigating clinical overlap

Friedrich Erdlenbruch 1,✉, Andreas Thieme 1, Christel Depienne 2, Dagmar Timmann 1, Stoyan Popkirov 1
PMCID: PMC12730797  PMID: 41450530

Abstract

Background

Functional movement disorders (FMDs) are commonly classified along canonical non-ataxic movement disorder patterns, creating a potential blind spot for frequently observed ataxia-like presentations. At the same time, normal diagnostic findings and episodic symptom variability in some cerebellar ataxias predispose to an incorrect FMD diagnosis.

Cases

We present three cases that illustrate pitfalls in the differential diagnosis of ataxia. First, a patient treated for presumed immune-mediated cerebellar ataxia was diagnosed with FMD based on clinical signs. Next, a patient with intermittent and inconsistent symptoms was diagnosed with FMD after extensive exclusionary workup, but was then found to have a novel type of spinocerebellar ataxia. The third patient had a genetically confirmed spinocerebellar ataxia but developed additional functional motor symptoms.

Conclusion

Differentiating cerebellar ataxias from FMDs and recognising mixed presentations is essential. Enhanced clinical awareness and systematic diagnostic evaluation are crucial to avoid misdiagnosis and ensure optimal treatment.

Keywords: FUNCTIONAL NEUROLOGICAL DISORDER, CEREBELLAR ATAXIA

Introduction

Neurologists classify functional movement disorders (FMDs) along canonical patterns of abnormal movement such as dystonia, tremor or myoclonus.1 This practice has low inter-rater reliability and fails to accommodate the fact that most patients fit more than one pattern or are otherwise unclassifiable.1 2 Furthermore, it almost always leaves out ataxia, creating a potential blind spot of differential diagnosis. Although the full picture of cerebellar dysfunction, including oculomotor abnormalities and dysarthria, is rarely encountered in FMD, a pattern of motor incoordination reminiscent of the motor symptom ‘ataxia’ is common.3 4 Furthermore, oculomotor or dysarthric features can be absent in small cerebellar lesions and in the early phases of some progressive conditions.

Cerebellar ataxias include a broad spectrum of acquired, hereditary and sporadic forms characterised by impaired motor coordination and gait instability, which can often be linked to focal cerebellar disease or genetic abnormalities. Recent advances in molecular testing have uncovered monogenetic causes of late-onset cerebellar ataxias (e.g., FGF14 and RFC1) in cohorts previously labelled as ‘sporadic’,5 highlighting the evolving landscape of cerebellar disorders and the need for detailed phenotyping and aetiologic evaluation. In parallel, FMDs have gained recognition as valid and potentially treatable conditions, yet misdiagnosis and iatrogenic harm remain pervasive challenges. Although the principle of clinical diagnosis based on specific signs and features has supplanted traditional diagnosis by exclusion and has led to more reliable diagnoses,6 7 an awareness of overlapping presentations and diagnostic pitfalls remains important.8 9 To highlight diagnostic challenges of incoordination at the interface of functional and cerebellar disorders, we present three illustrative cases from our specialist ataxia and FMD outpatient clinics.

Case series

Case 1

This female Caucasian patient was referred to our ataxia outpatient clinic at the age of 56 years with a presumed cerebellar syndrome with progressive incoordination and gait disorder as well as right-sided sensorimotor hemiparesis. Her symptoms began following a series of infections and vaccinations, initially manifesting as altered body perception and imbalance when riding public transport. Over time, she developed marked difficulties with goal-directed movements, accompanied by motor restlessness and episodic limb stiffness. She became increasingly dependent on a walker and experienced chronic dizziness, dysphagia and significant mental fatigue. Medical history included alcohol addiction between the ages of 15 and 35 (>20 years sober on presentation) as well as a long-standing post-traumatic stress disorder. She was previously diagnosed with a subacute immune-mediated brainstem/cerebellar syndrome despite normal cerebrospinal fluid findings and treated with methylprednisolone pulse therapy, followed by rehabilitation, none of which improved the symptoms. During follow-up assessments, the symptoms had progressively worsened, prompting further investigation, including short-read genome sequencing. This included bioinformatic analysis (ExpansionHunter) for the most common spinocerebellar ataxias,10 which did not reveal any pathogenic repeat expansion. Brain MRI also showed no cerebellar atrophy or other abnormalities.

On examination: inconsistent gaze restriction during smooth pursuit to the right, without restrictions during natural observation or on passive head rotation with visual fixation. Right-sided drift without pronation on arm elevation. Fine motor performance of the right hand was slow and strained during explicit testing but unimpaired during spontaneous activities such as removing glasses or adjusting clothing. Give-way weakness during isometric strength testing. A positive Hoover sign on the right was elicited. Finger-to-nose test on the right was unsteady but not dysmetric. Tactile sensitivity was reduced on the right side. Deep tendon reflexes were symmetric. On standing with eyes closed, there was increased body sway which visibly stabilised during dual-tasking (identifying numbers drawn on the back). Gait was broad-based, slow and very cautious; marked improvement when asked to jog or to walk sideways.

Functional neurological disorder was diagnosed based on the positive clinical signs, accounting for both the incoordination and the hemiparesis.

Case 2

This male patient was referred to our outpatient FND clinic at the age of 37 years because of a presumed functional neurological disorder. His symptoms manifested 5 years prior during a wedding as a transient episode of dysarthria and impaired coordination. Over the following years, similar episodes recurred intermittently and eventually evolved into a persistent disorder. He experienced recurrent falls, some of which resulted in bone fractures. His family history was unremarkable for neurological disorders. The patient was seen in a range of neurological outpatient and inpatient settings, where imaging, electrophysiology and laboratory analyses were all negative and various diagnoses, including panic attacks, dissociative/psychogenic seizures and FMD, were given. At one point, episodic ataxia was considered, but after exome sequencing in 2021 revealed no pathogenic variants (e.g., KCNA1, CACNA1A, CACNB4, SLC1A3 and UBR4), a diagnosis of FMD was given. Genetic panel testing for ataxias with additional spinocerebellar ataxia repeat expansion analysis was repeated in 2023 but was also negative.

On examination: mild dysarthria with slowing of speech, which was consistent and did not improve or worsen with different speech exercises or throughout the examination. Gait was broad-based, slow and very cautious. Sideways walking appeared somewhat better; tandem gait was not possible. Apart from minor variations, however, there were no clear inconsistencies or other unambiguously positive signs of FMD. On subsequent examination in a tertiary ataxia subspecialty clinic, saccadic dysmetria, gaze-evoked nystagmus on horizontal testing and interruptions of smooth pursuit were noted.

Based on the examination findings and the history of late-onset episodic ataxia that later became progressive, spinocerebellar ataxia type 27B (SCA27B) was suspected. Targeted genetic testing was initiated within the scope of a research study, confirming a compound-heterozygous GAA repeat expansion (allele 1: 498 repeats/ allele 2: 684 repeats) in the FGF14 gene.

Case 3

This female patient was referred to our ataxia outpatient clinic at the age of 60 years with the diagnosis of spinocerebellar ataxia type 6 (SCA6). Retrospectively, she had developed a slowly progressive balance disorder 10–15 years prior to her first presentation. A diagnostic work-up was initiated in 2018 after she noted left-sided leg weakness while operating the clutch of her car. Brain MRI revealed vermian cerebellar atrophy, and molecular genetic testing confirmed the familial SCA6 diagnosis (22±1 CAG-copies in the CACNA1A gene).

On initial examination (ataxia clinic), she demonstrated cerebellar oculomotor dysfunction, mild dysarthria and marked stance and gait ataxia. Depressive symptoms and difficulty coping with her illness were also noted. Following significant psychosocial stressors in 2022 (severe conflicts with a close friend and breaking off contact with a family member), the patient experienced an abrupt gait deterioration. In the context of knee pain, she developed marked left leg weakness and severe fatigue. Orthopaedic and neurological evaluations had recommended a peroneal orthosis, use of a walker and follow-up MRI.

On examination (FND clinic), she had inconsistent strength in the legs with marked give-way weakness and positive Hoover’s sign on the left. Gait with a walker was cautious, slow and reminiscent of a left-sided steppage gait. Without the walker, the left leg was stiff and advanced via circumduction. Gait was characterised by excessive balancing efforts with superfluous compensatory movements. During sideways and backward walking, gait patterns normalised almost completely.

Based on these findings, an additional diagnosis of FMD with limb weakness and gait instability superimposed on her pre-existing cerebellar ataxia was made.

Discussion

Our selected cases illustrate the importance of clinical diagnosis based on physical examination findings, the challenges of comorbidity, the perils of overvaluing minor inconsistencies in neurological presentation and the pitfalls of a diagnosis by exclusion. In particular, episodic ataxias or ataxias with episodic symptoms are highly prone to misdiagnosis owing to the fluctuating nature of their clinical manifestations.

A range of so-called positive clinical and even electrophysiological signs has been developed and validated for the diagnostic classification of (functional) tremor, dystonia, myoclonus and paresis. However, very few approaches towards differentiating cerebellar ataxia from functional incoordination have been established. Observable features of functional gait ataxia such as excessive slowness and extreme caution are common among cerebellar ataxia patients and have thus shown only moderate specificity for FMD.11 Inconsistencies in hand dysmetria have been studied using a custom kinematic recording system,12 but clinical testing in routine encounters is yet to be established. Future research should explore specific clinical signs that can help differentiate functional incoordination from cerebellar ataxia. Finally, subtle oculomotor abnormalities can provide valuable clues regarding underlying or comorbid cerebellar disease.

The classic FMD criterion of ‘incongruence’ has recently been critiqued for necessitating medical omniscience.7 Indeed, even state-of-the-art genetic testing for cerebellar ataxias does not rule out a hereditary disorder, as our case of SCA27B, a surprisingly common late-onset cerebellar ataxia first discovered in 2023, demonstrates. Once a sense of having ‘ruled out’ differential diagnoses is established, a set of confirmation biases such as selective perception and observer-expectancy effects can seemingly strengthen an FMD diagnosis, while its foundation (unambiguous specific clinical signs) remains weak. As in other movement disorders, FMD comorbidity is common and should be considered at a low threshold. Patients with cerebellar ataxias could be particularly prone to developing FMD due to illness-specific psychosocial stressors and expectancy effects, but potentially also due to the dysfunction of predictive cerebellar circuit functions, as abnormal predictive processing is considered a key mechanism of FMD. Finally, functional symptoms can occur in the prodromal phases of progressive cerebellar disease,13 much like in other neurodegenerative diseases.14 15

Acknowledgements

We acknowledge support by the Open Access Publication Fund of the University of Duisburg-Essen.

Footnotes

Funding: FE received funding from the DFG in the framework of the DFG Clinician Scientist Programme UMEA (FU 356/12-2). SP is supported by a BMBF Advanced Clinician Scientist Programme UMEA² (01EO2104). The funders had no involvement in the study design; in the collection, analysis and interpretation of the data; in the writing of the report; and in the decision to submit the paper for publication.

Patient consent for publication: Consent obtained directly from patient(s)

Ethics approval: We confirm that this work did not require review or approval by an institutional review board. According to the local Ethics Committee (Ethik-Kommission der Medi­zinis­chen Fakultät der Uni­ver­sität Duisburg-Essen), this retrospective case series of patients treated at our institution does not require formal ethical review or approval. Written informed consent for publication of clinical details was obtained from all three patients. We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. Participants gave informed consent to participate in the study before taking part.

Provenance and peer review: Not commissioned; externally peer reviewed.

Data availability statement

All data relevant to the study are included in the article or uploaded as supplementary information.

References

  • 1.Lidstone SC, Costa-Parke M, Robinson EJ, et al. Functional movement disorder gender, age and phenotype study: a systematic review and individual patient meta-analysis of 4905 cases. J Neurol Neurosurg Psychiatry . 2022;93:609–16. doi: 10.1136/jnnp-2021-328462. [DOI] [PubMed] [Google Scholar]
  • 2.Nielsen G, Ricciardi L, Meppelink AM, et al. A Simplified Version of the Psychogenic Movement Disorders Rating Scale: The Simplified Functional Movement Disorders Rating Scale (S-FMDRS) Mov Disord Clin Pract. 2017;4:710–6. doi: 10.1002/mdc3.12475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Butler M, Shipston-Sharman O, Seynaeve M, et al. International online survey of 1048 individuals with functional neurological disorder. Eur J Neurol. 2021;28:3591–602. doi: 10.1111/ene.15018. [DOI] [PubMed] [Google Scholar]
  • 4.Macchi ZA, Kletenik I, Olvera C, et al. Psychiatric Comorbidities in Functional Movement Disorders: A Retrospective Cohort Study. Mov Disord Clin Pract. 2021;8:725–32. doi: 10.1002/mdc3.13226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Beijer D, Mengel D, Önder D, et al. The genetic landscape of sporadic adult-onset degenerative ataxia: a multi-modal genetic study of 377 consecutive patients from the longitudinal multi-centre SPORTAX cohort. EBioMedicine. 2025;115:105715. doi: 10.1016/j.ebiom.2025.105715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Perez DL, Aybek S, Popkirov S, et al. A Review and Expert Opinion on the Neuropsychiatric Assessment of Motor Functional Neurological Disorders. J Neuropsychiatry Clin Neurosci. 2021;33:14–26. doi: 10.1176/appi.neuropsych.19120357. [DOI] [PubMed] [Google Scholar]
  • 7.Stone J. Incongruence in FND: time for retirement. Pract Neurol. 2024;24:163–5. doi: 10.1136/pn-2023-003897. [DOI] [PubMed] [Google Scholar]
  • 8.Finkelstein SA, Popkirov S. Functional Neurological Disorder: Diagnostic Pitfalls and Differential Diagnostic Considerations. Neurol Clin. 2023;41:665–79. doi: 10.1016/j.ncl.2023.04.001. [DOI] [PubMed] [Google Scholar]
  • 9.Perez DL, Hunt A, Sharma N, et al. Cautionary notes on diagnosing functional neurologic disorder as a neurologist-in-training. Neurol Clin Pract. 2020;10:484–7. doi: 10.1212/CPJ.0000000000000779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Dolzhenko E, Deshpande V, Schlesinger F, et al. ExpansionHunter: a sequence-graph-based tool to analyze variation in short tandem repeat regions. Bioinformatics. 2019;35:4754–6. doi: 10.1093/bioinformatics/btz431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Herdman SJ, Hall CD, Eggers R, et al. Misclassification of patients with spinocerebellar ataxia as having psychogenic postural instability based on computerized dynamic posturography. Front Neurol. 2011;2:21. doi: 10.3389/fneur.2011.00021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Manto MU. Discrepancy between dysmetric centrifugal movements and normometric centripetal movements in psychogenic ataxia. Eur Neurol. 2001;45:261–5. doi: 10.1159/000052140. [DOI] [PubMed] [Google Scholar]
  • 13.Gelauff JM, Carson A, Ludwig L, et al. The prognosis of functional limb weakness: a 14-year case-control study. Brain. 2019;142:2137–48. doi: 10.1093/brain/awz138. [DOI] [PubMed] [Google Scholar]
  • 14.Matar E, Tinazzi M, Edwards MJ, et al. Functional Movement Disorder as a Prodromal Symptom of Parkinson’s Disease-Clinical and Pathophysiological Insights. Mov Disord. 2024;39:1952–9. doi: 10.1002/mds.29958. [DOI] [PubMed] [Google Scholar]
  • 15.Cabreira V, Zeidler M, McWhirter L, et al. Functional cognitive disorder in Alzheimer’s disease. J Neurol Sci. 2025;476:123618. doi: 10.1016/j.jns.2025.123618. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All data relevant to the study are included in the article or uploaded as supplementary information.


Articles from BMJ Neurology Open are provided here courtesy of BMJ Publishing Group

RESOURCES